Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1683
Peer-review started: December 30, 2023
First decision: January 16, 2024
Revised: January 29, 2024
Accepted: March 18, 2024
Article in press: March 18, 2024
Published online: May 15, 2024
Processing time: 130 Days and 17.5 Hours
Core Tip: The high colorectal cancer (CRC) mortality rate worldwide, despite the adequate availability of modern screening, diagnostic and treatment options, raises important research and clinical questions. In both low- and middle- income countries (LMICs), and minority populations of high-income countries, the paradox of underutilization of existing screening methods was observed. The lack of global, homogeneous guidelines and the absence of guidelines addressing CRC screening at the national level for LMICs, contribute to the confusing status in the management of screening of aforementioned populations. Global efforts should focus on medical education and vigilance of medical healthcare providers and patients, on exploring the socio-economic aspects, and on the use of technological innovations in telemedicine and artificial intelligence in clinical practice.
